Semaglutide Suppresses Cocaine Use and Dopamine Reward Signaling
Semaglutide suppressed cocaine taking, seeking behavior, and cocaine-evoked dopamine release, providing strong preclinical evidence for GLP-1 drugs in cocaine addiction treatment.
Quick Facts
What This Study Found
Semaglutide suppressed cocaine taking, seeking behavior, and cocaine-evoked dopamine release, providing strong preclinical evidence for GLP-1 drugs in cocaine addiction treatment.
Key Numbers
Measured cocaine self-administration, seeking behavior, and dopamine levels in nucleus accumbens. Semaglutide showed superiority over shorter-acting GLP-1 agonists.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Semaglutide suppressed cocaine taking, seeking behavior, and cocaine-evoked dopamine release, provid
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens.
- Published In:
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 98, 1-10 (2025)
- Authors:
- Aranäs, Cajsa(4), Caffrey, Antonia(3), Edvardsson, Christian E(6), Schmidt, Heath D, Jerlhag, Elisabet
- Database ID:
- RPEP-09966
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Semaglutide suppressed cocaine taking, seeking behavior, and cocaine-evoked dopamine release, providing strong preclinical evidence for GLP-1 drugs in cocaine addiction treatment.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09966APA
Aranäs, Cajsa; Caffrey, Antonia; Edvardsson, Christian E; Schmidt, Heath D; Jerlhag, Elisabet. (2025). Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 98, 1-10. https://doi.org/10.1016/j.euroneuro.2025.07.001
MLA
Aranäs, Cajsa, et al. "Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens.." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2025. https://doi.org/10.1016/j.euroneuro.2025.07.001
RethinkPeptides
RethinkPeptides Research Database. "Semaglutide suppresses cocaine taking, seeking, and cocaine-..." RPEP-09966. Retrieved from https://rethinkpeptides.com/research/aranas-2025-semaglutide-suppresses-cocaine-taking
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.